CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
WILMINGTON, MA
Loading...
Price History
Market Data
| Market Cap | 14.22B |
| P/E Ratio | - |
| P/B Ratio | 4.49 |
| EPS | - |
| Dividend Yield | - |
| D/E Ratio | 1.24 |
| Current Ratio | 1.29 |
| Currency | USD |
Key Financial Metrics
4.02B
Revenue
-144.34M
Net Income
-
EPS (Diluted)
1.01B
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
0.6%
Net Profit Margin
-3.6%
EBITDA
428.47M
Returns & Efficiency
Return on Assets (ROA)
-2.0%
Return on Equity (ROE)
-4.6%
Dividend Yield
-
EPS
-
Financial Health
Total Assets
7.14B
Total Debt
2.14B
Debt to Equity
1.24x
Current Ratio
1.29
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| HQ | WILMINGTON, MA |
| Fiscal Year | 2025 |
Peers
40.07B
P/E: --
40.07B
P/E: --
40.07B
P/E: --
EXACT SCIENCES CORP
EXAS
20.03B
P/E: --
INCYTE CORP
INCY
20.02B
P/E: --
16.56B
P/E: 41.2
EXELIXIS INC
EXEL
11.92B
P/E: 18.6
EXELIXIS, INC.
EXEL
11.92B
P/E: 18.6
Quick Links
Financial Statistics
Valuation
Market Cap$14.22B
P/E Ratio (TTM)-
Price to Book4.49
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin-
Operating Margin0.6%
Net Margin-3.6%
ROE-4.6%
ROA-2.0%
Leverage & Liquidity
Debt to Equity1.24
Current Ratio1.29
Total Debt$2.14B
Total Assets$7.14B
Stockholders' Equity$3.16B
Income Statement (FY 2025)
Revenue$4.02B
Gross Profit-
Operating Income$25.16M
Net Income$-144.34M
EPS (Diluted)-
Cash Flow (FY 2025)
Free Cash Flow$1.01B
Cash & Equivalents$213.77M
Revenue Growth-0.9%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 251 BALLARDVALE ST WILMINGTON, MA 01887 |
| Phone | 781-222-6000 |
| Incorporated | None, None |
| EIN | 061397316 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 49.23M |
| Stockholders' Equity | $3.16B |
| Cash & Equivalents | $213.77M |
Recent Filings
View All
SD
Specialized Disclosure
Specialized disclosure report (conflict minerals, etc.)
Filed: 2026-05-11
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-11
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-07
Local
S-8
Employee Plan Registration
Registration for employee benefit plan securities
Filed: 2026-05-07
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-05-07
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-05-06
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-05-06
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. |
| Ticker | CRL |
| Exchange | -- |
| Sector | Services |
| Industry | -- |
| Headquarters | WILMINGTON, MA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 14.22B |
| Revenue | 4.02B |
| Net Income | -144.34M |
| P/E Ratio | - |
| EPS | - |
| Net Margin | -3.6% |
| ROE | -4.6% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...